Low ATM protein expression and depletion of p53 correlates with olaparib sensitivity in gastric cancer cell lines
出版年份 2014 全文链接
标题
Low ATM protein expression and depletion of p53 correlates with olaparib sensitivity in gastric cancer cell lines
作者
关键词
-
出版物
CELL CYCLE
Volume 13, Issue 13, Pages 2129-2137
出版商
Informa UK Limited
发表日期
2014-06-13
DOI
10.4161/cc.29212
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- The genomic landscape of mantle cell lymphoma is related to the epigenetically determined chromatin state of normal B cells
- (2014) J. Zhang et al. BLOOD
- ATM down-regulation is associated with poor prognosis in sporadic breast carcinomas
- (2013) R. C. Bueno et al. ANNALS OF ONCOLOGY
- Concordance of ATM (Ataxia Telangiectasia Mutated) Immunohistochemistry between Biopsy or Metastatic Tumor Samples and Primary Tumors in Gastric Cancer Patients
- (2013) Hee Sung Kim et al. PATHOBIOLOGY
- DNA Damage Response-Related Proteins in Gastric Cancer: ATM, Chk2 and p53 Expression and Their Prognostic Value
- (2013) Hee Eun Lee et al. PATHOBIOLOGY
- Mutation at Intronic Repeats of the Ataxia-Telangiectasia Mutated (ATM) Gene and ATM Protein Loss in Primary Gastric Cancer with Microsatellite Instability
- (2013) Hee Sung Kim et al. PLoS One
- Are DNA Repair Factors Promising Biomarkers for Personalized Therapy in Gastric Cancer?
- (2012) Tarek Abdel-Fatah et al. ANTIOXIDANTS & REDOX SIGNALING
- Enhanced cytotoxicity of PARP inhibition in mantle cell lymphoma harbouring mutations in both ATM and p53
- (2012) Chris T. Williamson et al. EMBO Molecular Medicine
- The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
- (2012) Jordi Barretina et al. NATURE
- Global cancer statistics
- (2011) Ahmedin Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- MRE11 Deficiency Increases Sensitivity to Poly(ADP-ribose) Polymerase Inhibition in Microsatellite Unstable Colorectal Cancers
- (2011) E. Vilar et al. CANCER RESEARCH
- The Emerging Role of Poly(ADP-Ribose) Polymerase Inhibitors in Cancer Treatment
- (2011) Shahneen K. Sandhu et al. CURRENT DRUG TARGETS
- Olaparib in patients with recurrent high-grade serous or poorly differentiated ovarian carcinoma or triple-negative breast cancer: a phase 2, multicentre, open-label, non-randomised study
- (2011) Karen A Gelmon et al. LANCET ONCOLOGY
- Mitotic catastrophe: a mechanism for avoiding genomic instability
- (2011) Ilio Vitale et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- The PARP inhibitor olaparib induces significant killing of ATM-deficient lymphoid tumor cells in vitro and in vivo
- (2010) V. J. Weston et al. BLOOD
- The influence of heterochromatin on DNA double strand break repair: Getting the strong, silent type to relax
- (2010) Aaron A. Goodarzi et al. DNA REPAIR
- Poly(ADP)-Ribose Polymerase Inhibition: Frequent Durable Responses inBRCACarrier Ovarian Cancer Correlating With Platinum-Free Interval
- (2010) Peter C. Fong et al. JOURNAL OF CLINICAL ONCOLOGY
- Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
- (2010) Yung-Jue Bang et al. LANCET
- Protein Phosphatase 6 Interacts with the DNA-Dependent Protein Kinase Catalytic Subunit and Dephosphorylates -H2AX
- (2010) P. Douglas et al. MOLECULAR AND CELLULAR BIOLOGY
- ATM Deficiency Sensitizes Mantle Cell Lymphoma Cells to Poly(ADP-Ribose) Polymerase-1 Inhibitors
- (2010) C. T. Williamson et al. MOLECULAR CANCER THERAPEUTICS
- COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer
- (2010) S. A. Forbes et al. NUCLEIC ACIDS RESEARCH
- Targeting homologous recombination repair defects in cancer
- (2010) Bastiaan Evers et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Synthetic lethal targeting ofPTENmutant cells with PARP inhibitors
- (2009) Ana M. Mendes-Pereira et al. EMBO Molecular Medicine
- Impacts of fluorouracil-metabolizing enzymes on the outcomes of patients treated with S-1 alone or S-1 plus cisplatin for first-line treatment of advanced gastric cancer
- (2009) Wasaburo Koizumi et al. INTERNATIONAL JOURNAL OF CANCER
- Cellular radiosensitivity: How much better do we understand it?
- (2009) Penny Jeggo et al. INTERNATIONAL JOURNAL OF RADIATION BIOLOGY
- Inhibition of Poly(ADP-Ribose) Polymerase in Tumors fromBRCAMutation Carriers
- (2009) Peter C. Fong et al. NEW ENGLAND JOURNAL OF MEDICINE
- Uniparental disomies, homozygous deletions, amplifications, and target genes in mantle cell lymphoma revealed by integrative high-resolution whole-genome profiling
- (2008) S. Bea et al. BLOOD
- DNA repair deficiency as a therapeutic target in cancer
- (2008) Sarah A Martin et al. CURRENT OPINION IN GENETICS & DEVELOPMENT
- A synthetic lethal siRNA screen identifying genes mediating sensitivity to a PARP inhibitor
- (2008) Nicholas C Turner et al. EMBO JOURNAL
- S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial
- (2008) Wasaburo Koizumi et al. LANCET ONCOLOGY
- ATM Signaling Facilitates Repair of DNA Double-Strand Breaks Associated with Heterochromatin
- (2008) Aaron A. Goodarzi et al. MOLECULAR CELL
- Somatic mutations affect key pathways in lung adenocarcinoma
- (2008) Li Ding et al. NATURE
- Ataxia-telangiectasia: from a rare disorder to a paradigm for cell signalling and cancer
- (2008) Martin F. Lavin NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Expression status of ataxia-telangiectasia-mutated gene correlated with prognosis in advanced gastric cancer
- (2007) Bin Kang et al. MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now